Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens.
about
Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersSynthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system.2-Anilino-3-Aroylquinolines as Potent Tubulin Polymerization Inhibitors.Cost-effectiveness of palbociclib in hormone receptor-positive advanced breast cancer.Adverse event-related costs for systemic metastatic breast cancer treatment among female Medicaid beneficiaries.Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA.Assessment of costs associated with adverse events in patients with cancer.
P2860
Q28267134-249FEAD1-A679-44C9-A19D-5349E407295CQ34706060-3E3D93CF-3172-4C51-AA11-E609505F115FQ35568576-1D725746-5C46-4626-AA3F-98814229941AQ37338289-4E389AB4-F753-4680-9656-C746373E88E0Q38755322-EB21AE3F-2B66-478A-9115-FB66B0B1C9BDQ38804149-A20EFC87-AAE7-4F96-A4A5-E502C94752C9Q38840175-C28A69AE-AC75-43C0-A682-0CB01B14B20EQ47551703-DFBE2B7B-8A71-49DA-9CEB-FA0D06BC2171Q52589868-63DA2D8C-E937-4A45-9188-FE0150E411B0
P2860
Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification and cost of adv ...... d capecitabine based regimens.
@ast
Identification and cost of adv ...... d capecitabine based regimens.
@en
type
label
Identification and cost of adv ...... d capecitabine based regimens.
@ast
Identification and cost of adv ...... d capecitabine based regimens.
@en
prefLabel
Identification and cost of adv ...... d capecitabine based regimens.
@ast
Identification and cost of adv ...... d capecitabine based regimens.
@en
P2093
P2860
P356
P1433
P1476
Identification and cost of adv ...... d capecitabine based regimens.
@en
P2093
Anthony Masaquel
Deepa Lalla
Melissa Brammer
Ryan N Hansen
Sara A Hurvitz
Scott D Ramsey
Sean D Sullivan
Tripthi Kamath
P2860
P2888
P356
10.1186/2193-1801-3-259
P577
2014-05-21T00:00:00Z
P5875
P6179
1000620783